Skip to main content
Premium Trial:

Request an Annual Quote

Invicro, Yale Partner to Advance Biomarker Detection Tech

NEW YORK — Invicro said on Monday that it has partnered with the Yale University School of Medicine to refine an imaging-based tissue biomarker detection technology for clinical pathology applications.

Under the deal, Invicro — a Boston-based subsidiary of Konica Minolta — will work with Yale pathologist David Rimm to advance Quanticell, a technology that uses photostable and bright phosphor-integrated dots for quantitative, amplification-free detection of proteins at cellular and subcellular levels.

According to Invicro, Rimm and his research team will evaluate different assay conditions to assess Quanticell's performance for quantifying HER-2 expression across a wider dynamic range than chromogenic-based immunohistochemistry.

Additional terms of the partnership were not disclosed.

"With his unmatched knowledge and experience in anatomical pathology, product commercialization, and late-stage clinical trials … Rimm is a leading pioneer in the quantitative pathology space," Ken Bloom, chief medical officer for advanced pathology solutions at Invicro, said in a statement. "I am highly confident that his efforts will support the advancement of Quanticell for specific drug development initiatives."

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.